Mengzhao Wang

9.1k total citations · 1 hit paper
229 papers, 3.9k citations indexed

About

Mengzhao Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mengzhao Wang has authored 229 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Pulmonary and Respiratory Medicine, 153 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Mengzhao Wang's work include Lung Cancer Treatments and Mutations (127 papers), Lung Cancer Research Studies (71 papers) and Cancer Immunotherapy and Biomarkers (56 papers). Mengzhao Wang is often cited by papers focused on Lung Cancer Treatments and Mutations (127 papers), Lung Cancer Research Studies (71 papers) and Cancer Immunotherapy and Biomarkers (56 papers). Mengzhao Wang collaborates with scholars based in China, United States and South Korea. Mengzhao Wang's co-authors include Yan Xu, Minjiang Chen, Jing Zhao, Wei Zhong, Hongge Liang, Caicun Zhou, Longyun Li, James Chih‐Hsin Yang, Wu‐Chou Su and Li Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mengzhao Wang

218 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

2012 776 citations Mengzhao Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mengzhao Wang China	31	2.5k	2.4k	973	658	257	229	3.9k
Jordi Remón France	34	2.4k 1.0×	2.1k 0.9×	1.0k 1.0×	977 1.5×	171 0.7×	175	3.7k
Yukio Hosomi Japan	28	2.1k 0.9×	2.5k 1.0×	878 0.9×	429 0.7×	236 0.9×	189	3.7k
Koichi Minato Japan	29	1.6k 0.6×	2.1k 0.8×	781 0.8×	364 0.6×	252 1.0×	171	3.1k
Qinghua Zhou China	29	1.7k 0.7×	1.5k 0.6×	1.2k 1.2×	926 1.4×	235 0.9×	215	3.8k
Kye Young Lee South Korea	26	2.4k 1.0×	1.8k 0.8×	1.4k 1.4×	989 1.5×	103 0.4×	118	3.7k
Gee‐Chen Chang Taiwan	31	1.6k 0.6×	1.4k 0.6×	1.6k 1.6×	784 1.2×	101 0.4×	55	3.3k
Caicun Zhou China	36	3.4k 1.4×	3.6k 1.5×	1.6k 1.6×	957 1.5×	258 1.0×	209	5.6k
Eun Kyung Cho South Korea	29	2.1k 0.9×	2.0k 0.8×	756 0.8×	397 0.6×	186 0.7×	134	3.6k
Zhihong Chen China	29	1.4k 0.6×	1.3k 0.5×	1.1k 1.1×	720 1.1×	125 0.5×	144	2.9k
Wenfeng Fang China	33	2.4k 1.0×	3.4k 1.4×	1.1k 1.1×	890 1.4×	311 1.2×	201	4.9k

Countries citing papers authored by Mengzhao Wang

Since Specialization

Citations

This map shows the geographic impact of Mengzhao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengzhao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengzhao Wang more than expected).

Fields of papers citing papers by Mengzhao Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengzhao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengzhao Wang. The network helps show where Mengzhao Wang may publish in the future.

Co-authorship network of co-authors of Mengzhao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengzhao Wang. A scholar is included among the top collaborators of Mengzhao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengzhao Wang. Mengzhao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Mengzhao, et al.. (2025). Disentangling Inter- and Intra-Video Relations for Multi-Event Video-Text Retrieval and Grounding. IEEE Transactions on Image Processing. 34. 7558–7571.

Du, Cheng‐Feng, Mengzhao Wang, Mingyu Fu, et al.. (2025). MXene‐Controlled PTFE Release for Ultra‐Low Friction PEEK Composites. Advanced Functional Materials. 36(14). 3 indexed citations

Huang, Hui, et al.. (2024). The Clinical Analysis of Checkpoint Inhibitor Pneumonitis with Different Severities in Lung Cancer Patients: A Retrospective Study. Journal of Clinical Medicine. 13(1). 255–255. 3 indexed citations

Li, Rongzhen, et al.. (2024). Comparison of radiotherapy versus surgical resection following neoadjuvant chemoimmunotherapy in potentially resectable stage III non-small-cell lung cancer: A propensity score matching analysis. Lung Cancer. 194. 107884–107884. 4 indexed citations

Lu, Tao, Yan Xu, Minjiang Chen, et al.. (2024). The outcomes of different regimens depend on the molecular subtypes of pulmonary large‐cell neuroendocrine carcinoma: A retrospective study in China. Cancer Medicine. 13(1). e6834–e6834. 7 indexed citations

Du, Yang, Ruili Pan, Xiaotong Zhang, et al.. (2024). Tocilizumab for advanced non-small cell lung cancer with concomitant inflammatory cachexia: A single-centre study.. Journal of Clinical Oncology. 42(16_suppl). 2647–2647. 2 indexed citations

Pan, Ruili, Minjiang Chen, Jing Zhao, et al.. (2022). Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis. Thoracic Cancer. 13(7). 1059–1066. 4 indexed citations

Ni, Jun, Xiaotong Zhang, Hanping Wang, et al.. (2021). Clinical characteristics and prognostic model for extensive‐stage small cell lung cancer: A retrospective study over an 8‐year period. Thoracic Cancer. 13(4). 539–548. 9 indexed citations

Si, Xiaoyan, Jinwan Wang, Ying Cheng, et al.. (2020). A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 12. 3863580889–3863580889. 11 indexed citations

10.

Ni, Jun, Han‐Ping Wang, Xiaoyan Si, et al.. (2020). Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study. Thoracic Cancer. 11(7). 1869–1875. 2 indexed citations

11.

Si, Xiaoyan, Ruili Pan, Shaohua Ma, et al.. (2020). Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer. Thoracic Cancer. 12(3). 357–363. 18 indexed citations

12.

Si, Xiaoyan, Hanping Wang, Xiaotong Zhang, et al.. (2020). Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases. Thoracic Cancer. 11(8). 2339–2342. 3 indexed citations

13.

Xing, Puyuan, Shouzheng Wang, Di Ma, et al.. (2019). Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in China. Targeted Oncology. 14(3). 325–333. 8 indexed citations

14.

Wei, Hao, et al.. (2018). Effect of Supplementary Light Source on Quality of Grafted Tomato Seedlings and Expression of Two Photosynthetic Genes. Agronomy. 8(10). 207–207. 17 indexed citations

15.

Fan, Yun, Xuehua Zhu, Yan Xu, et al.. (2017). Cell-Cycle and DNA-Damage Response Pathway Is Involved in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(1). 209–216. 45 indexed citations

16.

Xu, Yan, Yiduo Sun, Jing Zhao, et al.. (2017). [Ocular Metastasis in Lung Cancer: a Retrospective Analysis in a Single Chinese Hospital and Literature Review].. SHILAP Revista de lepidopterología. 20(5). 326–333. 12 indexed citations

17.

Zhang, Qinfeng, et al.. (2015). [Pleural epithelioid hemangioendothelioma: a case report and review of the literature].. PubMed. 38(3). 174–8. 4 indexed citations

18.

Zhang, Xu‐Chao, Li Zhang, Changli Wang, et al.. (2013). [Consensus on dignosis for ALK positive non-small cell lung cancer in China, the 2013 version].. PubMed. 42(6). 402–6. 22 indexed citations

19.

Li, Longyun, Wei Zhong, Meilin Liao, et al.. (2012). [A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China].. SHILAP Revista de lepidopterología. 15(6). 332–9. 5 indexed citations

20.

Wang, Mengzhao, Longyun Li, Nan Su, et al.. (2004). [Efficacy and safety of arbidol in treatment of naturally acquired influenza].. PubMed. 26(3). 289–93. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact